Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-08-23
1996-07-09
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483114, 5483011, 546 15, 5462827, 546196, 5462841, 5462817, 549404, 549408, 549437, 514456, 514462, 514469, 514278, 514337, A61K 31415, C07D40506
Patent
active
055345360
ABSTRACT:
Fused phenol compounds of the formula (I): ##STR1## (wherein R.sup.1 and R.sup.2 each, independently, is H, halogen, trifluoromethyl, cyano, (substituted) alkyl, alkoxy, cycloalkyl, COOH, COOR.sup.6 (in which R.sup.6 is C1-6 alkyl), alkenyl or R.sup.1 and R.sup.2, taken together, is --CH.dbd.CH--CH.dbd.CH--, when R.sup.1 and R.sup.2 are ortho to each other; A is alkylene, alkenylene, oxyalkylene or ##STR2## (in which m is 1-6); B is a monocyclic hetero ring containing a nitrogen atom; G is --OR.sup.3A or --NR.sup.3B R.sup.3C (in which R.sup.3A, R.sup.3B and R.sup.3C each, independently, is H, alkyl, acyl, or alkoxyalkyl); R.sup.4 and R.sup.5 each, independently, is H, alkyl, or R.sup.4, R.sup.5 together with the carbon atom to which they are attached represent C4-7 cycloalkyl; and n is 1-3; non-toxic salts thereof, non-toxic acid addition salts thereof, and hydrates thereof.
The compounds of the formula (I) have inhibitory activities on TXA.sub.2 synthetase and on 5-lipoxygenase and/or a scavenging activity on active oxygen species, and are useful for the prevention and/or the treatment of thrombosis, arteriosclerosis, ischemic heart diseases or brain diseases, bronchial asthma, renal inflammation, rheumatism, arthritis, gout, psoriasis, ulcerative colitis, trichophytosis, cardiac infarction, allergic diseases, etc.
REFERENCES:
patent: 2868691 (1959-01-01), Porush et al.
patent: 3095355 (1963-06-01), Abramson et al.
patent: 4775679 (1988-10-01), Chang et al.
patent: 4857516 (1989-08-01), Terao et al.
patent: 4978761 (1990-12-01), Goto et al.
Lau et al. CA 116:173926 1992.
Belanger et al. CA 116:106078 1991.
Chemical Abstracts, vol. 73, No. 15, 12 Oct. 1970, Columbus, Ohio, US; Abstract No. 77054k, M. Murakami et al, "5-Substituted methyl-6-chromanol derivatives as antioxidants", p. 353, col. 2, *abstract*, and JP-A-45 014 787 (Yamanouchi Pharmaceuticl Co., Ltd. 25 May 1970.
Journal Of Medicinal Chemistry, vol. 10, No. 4, 1967, Washington, US, pp. 657-660, W. A. Skinner et al, "Structure-Activity Relations in the Vitamin E Series. I. Effects of 5-Methyl Substitution on 6-Hydroxy-2,2,5,7,8-pentamethylchroman", p. 658, Example 18, Table I.
Bulletin Of The Chemical Society Of Japan, vol. 52, No. 4, 1979, Tokyo, JP, pp. 1143-1146, K. Murayama et al, "Synthesis of Methyl Substitute Chromanol. An Analogue of Vitamin K", p. 1145, col. 1, Example 6B.
Database WPI-Week 9401, Derwent Publications Ltd., London, GB; An 94-002287 & JP-A-5 310 724 (EISAI Co., Ltd.) 22 Nov. 1993-*Abstract*.
Nambu Fumio
Ohuchida Shuichi
Toda Masaaki
Fan Jane
Ono Pharmaceuticals Co. Ltd.
LandOfFree
Fused phenol derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused phenol derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused phenol derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1867550